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Summary
Autosomal dominant medullary cystic disease
(ADMCKD) is an interstitial nephropathy that has mor-
phologic and clinical features similar to autosomal re-
cessive nephronophthisis. The typical renal dysfunction
associated with ADMCKD results mainly from a defect
in urinary concentration ability, although results of uri-
nalysis are normal. Recently, a locus on chromosome 1
was associated with ADMCKD, in DNA from two large
Cypriot families, and genetic heterogeneity was inferred.
We describe the genomewide linkage mapping of a new
locus for medullary cystic disease, ADMCKD2, on chro-
mosome 16p12 in a four-generation Italian pedigree.
The family with ADMCKD2 fulfills the typical diag-
nostic criteria of ADMCKD, complicated by hyperuri-
cemia and gouty arthritis. Marker D16S3036 shows a
maximum two-point LOD score of 3.68, and the defined
critical region spans 10.5 cM, between D16S500 and
SCNN1B1–2. Candidate genes included in the critical
region are discussed.
Introduction
Autosomal dominant medullary cystic disease
(ADMCKD; MIM 174000) is a renal disorder charac-
terized by structural defects in the renal tubules, which
lead to a reduction of urine concentrating ability and a
decrease in sodium conservation. The disease progresses
toward renal failure, which generally requires dialysis
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or transplantation in patients aged !50 years. The dis-
ease is, however, heterogeneous in several clinical as-
pects, including age at onset, rate of progression, and
clinical appearance. This variability contributes to the
diagnosis of ADMCKD being either rare or confused
with other clinical entities. ADMCKD is usually diag-
nosed in the third or fourth decade of life; however, cases
of children with the disease, with slower progression
toward renal failure, are not uncommon (Gardner
1971). Renal symptoms are mainly defects in urinary
concentration ability with normal results of urinalysis.
The presence of small cysts in renal medulla is a central
feature of the disease, although the cysts may be absent
in the early stages. Discovery of these medullary cysts
may also be confounded by the presence of cysts ac-
quired as a result of chronic renal failure, in some pa-
tients. In the most frequent presentation of ADMCKD,
which is characterized by tubulointerstitial fibrosis and
thickening of the tubular basement membrane, renal
pathologic findings are not specific and are similar to
those found in other pathological entities such as juve-
nile-onset nephronophthisis (NPH; MIM 256100). The
major difference between ADMCKD and NPH is the
relative inheritance pattern, which is recessive in the lat-
ter, with typical onset of renal symptoms in early child-
hood and rapid evolution toward renal failure in the
second decade of life (Hildebrandt et al. 1992; Neumann
et al. 1997). Recent advances in the molecular genetics
of NPH have helped differentiate between the two en-
tities (Hildebrandt et al. 1997; Saunier et al. 1997; Chris-
todoulou et al. 1998; Fuchshuber et al. 1998; Scolari et
al. 1998; Stavrou et al. 1998).
A clear-cut definition for diagnosis of ADMCKD was
needed for further differentiation among ADMCKD
phenotypes. This led us to define several criteria for the
diagnosis of ADMCKD (Scolari et al. 1998; see Meth-
ods), on the basis of family inheritance and clinical and
pathological characteristics, including associated symp-
toms such as hyperuricemia. Recently, genetic linkage of
ADMCKD to the ADMCKD1 locus was established on
chromosome 1 (Christodoulou et al. 1998). In the pre-
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Figure 1 Pedigree of the family with ADMCKD2. Haplotypes for markers D16S405, D16S500, D16S3017, and markers D16S3036,
D16S3041, SCNN1B1–2, and D16S420, are shown from top to bottom. The disease-associated haplotype is boxed. Second-generation inferred
haplotypes are shown between brackets.
sent article, we report genomewide linkage analysis of
DNA from a large family and identification of a new
locus associated with ADMCKD, thus showing the ge-
netic heterogeneity of this clinically homogeneous renal
disorder.
Subjects and Methods
Subjects and Diagnostic Criteria
The four-generation Italian family, which included 10
members (4 men and 6 women) affected by ADMCKD
and diagnosed as indicated below, is depicted in figure
1. Four affected members (III-3, III-6, III-9, and IV-6)
were given a clinical and histological diagnosis of
ADMCKD; three members (II-3, III-4, and IV-1) had
only a clinical diagnosis of ADMCKD; and three de-
ceased relatives (I-1, II-1, and II-4) had a diagnosis of
chronic nephritis listed on their death certificates. Five
affected family members (II-3, III-3, III-6, III-9, and IV-
6) had hyperuricemia (that required specific treatment
with allopurinol) associated with ADMCKD; in two
subjects (II-3 and III-9), hyperuricemia was complicated
by gouty arthritis. The age at diagnosis of ADMCKD
ranged from 16 to 54 years (mean age, 31.5 years). Renal
cysts were documented by sonogram in one subject (II-
3). Twelve available members (III-1, III-2, III-5, III-7, III-
8, III-10, III-11, III-12, IV-2, IV-3, IV-4, and IV-5) were
screened and proved to be negative for the disease (see
table 1).
Diagnostic criteria were as follows: (1) autosomal
dominant inheritance; (2) defective urine concentration
with polyuria, isosthenuria, and relatively normal uri-
nalysis results; (3) normal- or small-sized kidneys with
occasional small medullary cysts; and (4) renal histologic
findings characterized by tubular-interstitial fibrosiswith
infiltrates, tubular atrophy, and thickening of the tubular
basement membrane with periodic acid Schiff–positive
material. Available family members were considered
healthy if they had results showing normal renal func-
tion, negative renal sonography, negative urinalysis, and
urinary osmolality 1800 mOsm/l, after overnight de-
hydration. In subjects with chronic renal insufficiency,
hyperuricemia was defined as an elevation of plasma
urate levels disproportionate to the degree of renal in-
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Table 1
Clinical, Biochemical, and Histological Findings of ADMCKD2 Family
Subject Diagnosis
Age at
Diagnosis_Age
at Screening (years)
Morning
Urinary
Osmolarity
(mOsm
H2O/kg) Renal Ultrasound
Renal
Histology
Serum
Creatinine/
Uric Acid
(mg/dl)
II-3 ADMCKD 54_ 300 Small kidneys with cysts ND 2/12.0
III-1 NO _44 860 Negative ND .8/4.7
III-2 NO _43 900 Negative ND .9/ND
III-3 ADMCKD 18_ 300 Small kidneys w/o cysts TIN 1.5/9.6
III-4 ADMCKD 25_ 330 Small kidneys w/o cysts ND 1.6/5.9
III-5 NO _36 861 Negative ND .8/ND
III-6 ADMCKD 30_ 315 Small kidneys w/o cysts TIN 1.3/9.2
III-7 NO _45 900 Negative ND .9/4.5
III-8 NO _44 895 Negative ND .7/4.2
III-9 ADMCKD 29_ 295 Small kidneys w/o cysts TIN 1.7/12
III-10 NO _38 910 Negative ND .97/2.8
III-11 NO _37 805 Negative ND .8/ND
III-12 NO _35 900 Negative ND .9/3.1
IV-1 ADMCKD 16_ 310 Small kidneys w/o cysts ND 1.6/5.5
IV-2 NO _23 1054 Negative ND .7/2.8
IV-3 NO _21 1183 Negative ND .8/
IV-4 NO _22 857 Negative ND .7/2.3
IV-5 NO _10 812 Negative ND .6/ND
IV-6 ADMCKD 18_ 330 Normal kidneys w/o cysts TIN 1.5/9.5
NOTE.—NO  normal phenotype, w/o  without, ND  not done, and TIN  Tubulo-interstitial nephritis.
sufficiency in subjects with chronic renal insufficiency
(Murray and Goldberg 1975).
Linkage Analysis
After informed consent, a 10-ml venous blood sample
was obtained from six affecteds and seven healthy rel-
atives. DNA was extracted from peripheral blood lym-
phocytes as described elsewhere (Sambrook et al. 1989).
A genomewide microsatellite screening was done with
358 highly polymorphic fluorescent markers (Gyapay et
al. 1994; Dib et al. 1996). This set of markers, which
are formatted and properly fluorescence-labeled to allow
efficient multiplexing on an automated sequencer, covers
all the autosomal chromosomes at an average reciprocal
distance of ∼10 cM.
The DNA from six affected members was subjected
to genomewide screening, and this preliminary set of
linkage data was analyzed with the MLINK program of
LINKAGE (Lathrop et al. 1984). Selected chromosomal
regions were further investigated with additional mark-
ers mapping telomeric and centromeric to the candidate
loci. For linkage calculations, ADMCKD was modeled
as an autosomal dominant trait with two liability classes
for age-dependent penetrance: 0.5 for age !15 years and
0.9 for age 115 years. The mutation rate was assumed
to be 105. Recombination frequencies (v) were consid-
ered to be equal between male and female subjects.
Marker alleles were assumed to be equifrequent in the
preliminary screening, whereas published allelic fre-
quencies were used for candidate loci calculations. Mul-
tipoint linkage analysis was done by LINKMAP (La-
throp et al. 1984), with the same parameters.
Results
The loci responsible for autosomal recessive NPH1
(Hildebrandt et al. 1997) and the ADMCKD1 form
(Christodoulou et al. 1998) were excluded from linkage
with the family in our previous study (Scolari et al. 1998;
G. Casari, unpublished material). We therefore consid-
ered this pedigree for genomewide linkage mapping. We
tested the probability of detecting significant linkage by
simulation analysis of 400 replicate pedigrees by using
SLINK (Weeks et al. 1990), considering the phenotype
with a frequency of 1 # 105. The maximum pairwise
LOD score obtained from 400 simulated pedigrees was
4.01 at A genomewide search was performedv  .02.
on all affected pedigree members. The selected loci sug-
gestive of linkage (LOD score 11.0) were further char-
acterized by testing all pedigree members’ DNA and by
locally increasing marker density.
The chromosome 16p locus, preliminarily identified
by the fluorescent markers D16S407 and D16S405
(LOD scores of 1.36 and 2.10 at and .05, re-v  .1
spectively), was confirmed with flanking markers. As
reported in table 2, marker D16S3036 achieves a max-
imum value of 3.68 with no recombination within the
disease locus. A 10.5-cM critical region betweenmarkers
D16S500 and SCNN1B1–2 (a polymorphic dinucleotide
repeat intragenic to the beta subunit of the epithelial
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Table 2
Two-Point LOD Score Values for 16p13–12 Markers
MARKER
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
D16S423 5.98 1.43 .54 .14 .15 .15 .06
D16S407 3.29 .69 1.27 1.36 1.15 .73 .24
D16S3114 .00 .02 .09 .13 .16 .14 .09
D16S405 2.28 1.66 2.10 2.06 1.64 1.02 .34
D16S500 1.91 2.02 2.43 2.35 1.87 1.20 .47
D16S3017 2.71 2.66 2.45 2.19 1.64 1.04 .41
D16S3036 3.69 3.62 3.36 3.01 2.27 1.46 .59
D16S3041 1.32 1.30 1.21 1.08 .83 .56 .28
SCNN1B1-2 2.97 .30 .29 .45 .43 .26 .07
D16S420 4.38 .38 .35 .62 .71 .51 .19
Figure 2 Multipoint linkage graph of the region surrounding
the ADMCKD2 locus.
sodium channel; Shimkets et al. 1994) was defined by
recombinant pedigree members. A common haplotype
(6_6_4) for markers D16S3017, D16S3036, and
D16S3041 is shared by all affected individuals (fig. 1);
individual IV-5 is a carrier of the disease-associated hap-
lotype but does not show the ADMCKD phenotype,
probably because of his young age (10 years), which is
much less than the age at onset among the other affected
family members (aged 16–20 years; table 1). Data from
subject III-4 was observed to be a double recombinant
for marker D16S3036 (or for markers D16S3017 and
D16S3036, because D16S3017 is not informative) in the
unaffected maternal haplotype.
The multipoint linkage graph (fig. 2) shows a multi-
point LOD score of 4.18 around D16S3036, thus iden-
tifying a new locus for ADMCKD that we named
“ADMCKD2.” Several partially characterized tran-
scripts (GeneMap98), and some known genes, map to
this critical region, including a phosphodiesterase gene
(Bolger et al. 1993), the multidrug resistance-associated
protein (Cole et al. 1992), the alanine aminotransferase
(Sohocki et al. 1997), the ubiquinol-cytochrome c re-
ductase complex core protein 2 precursor (Hosokawa
et al. 1989), the major Yo paraneoplastic antigen (Fa-
thallah Shaykh et al. 1991), the mu-crystallin (Kim et
al. 1992), and the uromodulin/Tamm-Horsfall glyco-
protein (Pennica et al. 1987). The genes coding for the
beta and gamma subunits of the kidney epithelial sodium
channel (SCNN1B and SCNN1G; Voilley et al. 1995)
are both localized to a 400-kb area in 16p12 at the
centromeric boundary of the critical region and have
been excluded from linkage to ADMCKD2 by the in-
tragenic marker SCNN1B1–2.
Discussion
ADMCKD has been considered a rare disease, on oc-
casion, because of a paucity of symptoms at early stages
and aspecific clinical and pathological features once re-
nal failure has developed. Furthermore, because of sev-
eral clinical and pathological similarities, ADMCKDhas
been easily confused with juvenile NPH. Advances in
the molecular genetics of renal cyst diseases have con-
tributed to a definite differentiation between these two
clinical entities. Recently, linkage analysis and positional
cloning approaches to recessive juvenile NPH have con-
tributed to the identification of a candidate gene map-
ping to chromosome 2q13, which is deleted in 165% of
patients with NPH1 (Hildebrandt et al. 1997).
An autosomal dominant form of ADMCKD has been
mapped to chromosome 1q21 in DNA from members
of two large Cypriot families affected with renal cysts,
hyperuricemia, and gout (Stavrou et al. 1998). No ob-
vious candidate genes have been proposed. The identi-
fication of a common haplotype in both families with
ADMCKD is probably due to a founder effect, fre-
quently observed in small island communities. In the
present article, we show evidence of linkage of
ADMCKD2 associated with chromosome 16p12 in
DNA from a large Italian family. In addition to the typ-
ical renal cysts, affected members show hyperuricemia
and gout. These symptoms are also found in the Cypriot
families and seem to identify a more homogeneous sub-
group of ADMCKD. Despite symptom and clinical ho-
mogeneity, the data in the present article show genetic
heterogeneity.
The 10.5-cM critical region of ADMCKD2 is dense
with transcripts (see Results), and the considerable size
of this genomic area renders a positional cloning ap-
proach difficult. Nonetheless, the localization of the uro-
modulin (also known as “Tamm-Horsfall protein”) gene
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to the ADMCKD2 critical region (Pook et al. 1993) is
interesting. Uromodulin is expressed mainly in the kid-
ney, where it is localized to the epithelial cells of the
thick ascending limb (TAL) of the Henle loops (Allen
and Tischer 1976), and has been functionally associated
with the water nonpermeability of the TAL (Sikri et al.
1978), a function that is altered in ADMCKD. Further-
more, abnormal peritubular and interstitial deposits of
uromodulin have been considered characteristic of NPH
and tubulointerstitial inflammatory disease (Resnick et
al. 1978; Zanger et al. 1978). However, DNA from ad-
ditional pedigrees will need to be analyzed to refine the
linkage mapping of the ADMCKD2 locus and to suit-
ably narrow the candidate region for a positional cloning
approach. The identification of the new ADMCKD2 lo-
cus and evidence of genetic heterogeneity, notwithstand-
ing the shared common phenotype, will further contrib-
ute to the understanding of cystic disease pathogenesis.
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